
FIRST MRNA CANCER VACCINE SUCCEEDS, POSITION NOW FOR ROBOTS, MEMORY MAKER MOVES TO STEM STOCK SELLING
By Nigam Arora

To gain an edge, this is what you need to know today.
Watch Arora Protection Band
Please click here for a chart of Moderna stock (MRNA).
Note the following:
- The Morning Capsule is about the big picture, not an individual stock. The chart of MRNA stock is being used to illustrate the point that innovation is providing great opportunities for investors.
- The chart shows a very large move in MRNA stock.
- RSI on the chart shows MRNA stock is now very overbought.
- There is a major breakthrough in cancer treatment from Moderna (MRNA) and Merck (MRK). Personalized mRNA cancer vaccine, intismeran, combined with Keytruda met the key endpoints in a Phase 3 melanoma trial, significantly reducing recurrence and distant metastasis compared with Keytruda alone.